- International counterpart to the FDA: How do other countries regulate drugs and devices?
Ruth Lopert, MD, Deputy Director, Pharmaceutical Policy & Strategy at Management Sciences for Health, and Adjunct Professor, Department of Health Policy & Management, George Washington University; former Chief Medical Officer in Australia’s Therapeutic Goods Administration (Feb 2016) - The Use of Surrogate Markers in Clinical Research
Vinay Prasad, MD, MPH – Hematologist-Oncologist, Assistant Professor of Medicine, Oregon Health Sciences University (Jan 2016) - Opioids and the FDA
Jane Ballantyne, MD, FRCA, University of Washington Professor of Education and Research, Director of UW Pain Fellowship
(Dec 2015) - Impact of the 21st Century Cures Act on FDA Medical Device Regulation
Sanket Dhruva, MD, Robert Wood Johnson Foundation Clinical Scholar, Yale University, VA Connecticut Healthcare System
(Sept 2015) - How physicians and theFDA are contributing to our addiction crisis
Andrew Kolodny, MD, Phoenix House Chief Medical Officer
(July 2015) - The Health Implications of Upcoming Trade Agreements (TPP and TTIP)
Peter Maybarduk, Director, Public Citizen’s Global Access to Medicines Program (June 2015) - How Psychiatric Drugs are Reviewed at the FDA
Erick Turner, MD, Associate professor of psychiatry at the Oregon Health and Science University, former medical officer at the FDA. (May 2015) - The Antibiotic Era
Scott Podolsky, MD, Director of the Center for the History of Medicine, Harvard, primary care internist at Massachusetts General Hospital (April 2015) - Health Policy Update: 3 New Articles on Current Issues
Aaron Kesselheim, MD, JD, MPH, Associate Professor, Harvard Medical School, currently visiting professor at Yale Law School teaching food and drug administration law (March 2015) - NPA FDA Task Force Special Webinar – AMSA Online Training: Antibiotic Resistance
ADAPT, PATH & HEAL preparation for 2015 AMSA Lobby Day with NPA FDA Taskforce members
Tejan Shah, Associate in Research, Program on Global Health and Technology Access, Duke University (Feb 2015) - Responsible Sharing of Clinical Data
Joseph Ross, MD, MHS, Yale University School of Medicine
(Dec 2014) - Anti-Infective Drug Advisory Committee Meeting
Reshma Ramachandran, MD, MPP, Candidate at Brown Medical School and Harvard Kennedy School; NPA FDA Task Force Co-Chair (Dec 2014) - Physiology is Not Fate
Rosemary Johann-Liang, MD, Pediatrician, NPA FDA Task Force Member, Rockville, MD
AccessAbility MedCare, CEO & Founder (Nov 2014) - Avoiding the antibiotic apocalypse: The role of incentives and regulation
Kevin Outterson, J.D., Boston University Health Law Program Director, Journal of Law, Medicine and Ethics Editor-in-Chief
(July 2014) - Antibiotics in animal feed: evidence of harmful effects, and what role can the FDA play in regulating this?
Michael Crupain, MD,MPH, Director of Food Safety and Sustainability Center at Consumer Reports (Feb 2014) - Expedited Approval Pathways
Dr. David Ross, MD, PhD, MBI, Associate Clinical Professor of Medicine George Washington University School of Medicine and Health Sciences (Sept 2013) - FDA Basics: History & Review Standards for Drugs and Devices
John Powers, MD FACP FIDSA, Associate Clinical Professor of Medicine George Washington University School of Medicine (August 2013)
Barbara Meier schreibt seit vielen Jahren für die NPAlliance Ratgeber und Testberichte. Dabei legt sie großen Wert auf die Ausführlichkeit sowie Richtigkeit ihrer Artikel. Sie zählt zu den wenigen Experten in ihrem Gebiet und hat sich über die letzten Jahren einen Namen in der Gesundheitsbranche gemacht.